发明名称 Methods of Reducing Apolipoprotein C-III
摘要 In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.
申请公布号 US2015216831(A1) 申请公布日期 2015.08.06
申请号 US201414261160 申请日期 2014.04.24
申请人 AMARIN PHARMACEUTICALS IRELAND LIMITED 发明人 Manku Mehar;Osterloh Ian;Wicker Pierre;Braeckman Rene;Soni Paresh;Zakrzewski Joseph S.
分类号 A61K31/232 主分类号 A61K31/232
代理机构 代理人
主权项 1. A method of reducing an APOC3 level of a subject on statin therapy and having baseline fasting triglycerides of about 200 mg/dl to about 499 mg/dl, the method comprising administering to the subject a pharmaceutical composition comprising about 1 g to about 4 g of ethyl eicosapentaenoate per day.
地址 Dublin IE